N. Sarita Shah*
1
, Abigail Wright†, Gill-Han Bai‡
2, Lucia Barrera§
2, Fadila Boulahbal¶
2, Nuria Martín-Casabona#
2, Francis Drobniewski**
2, Chris Gilpin††
2, Marta Havelkovᇇ
2, Rosario Lepe§§
2, Richard Lumb¶¶
2, Beverly Metchock*
2, Françoise Portaels##
2, Maria Filomena Rodrigues***
2, Sabine Rüsch-Gerdes†††
2, Armand Van Deun##
2, Veronique Vincent‡‡‡
2, Kayla Laserson*, Charles Wells*, and J. Peter Cegielski*
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †World Health Organization, Geneva, Switzerland; ‡Korean Institute of Tuberculosis, Seoul, Republic of Korea; §National Institute of Infectious Diseases, Buenos Aires, Argentina; ¶Institut Pasteur d’Algérie, Alger, Algeria; #Hospital Universitaris Vall d’Hebron, Barcelona, Spain; **Health Protection Agency, London, United Kingdom; ††Prince Charles Hospital, Brisbane, Queensland, Australia; ‡‡National Institute of Public Health, Scrobarova, Czech Republic; §§Institute of Public Health of Chile, Providencia Santiago, Chile; ¶¶Institute of Medical and Veterinary Science, Adelaide, South Australia, Australia; ##Institute of Tropical Medicine, Antwerp, Belgium; ***National Institute of Health, Porto, Portugal; †††National Reference Center for Mycobacteria, Borstel, Germany; ‡‡‡Institut Pasteur, Paris, France; 1Current affiliation: Albert Einstein College of Medicine, Bronx, New York, USA; 2Member: World Health Organization/International Union against Tuberculosis and Lung Diseases Network of Supranational Reference Laboratories
Main Article
Figure 1

Figure 1. Shading indicates 48 countries that submitted at least 1 isolate to participating Supranational Reference Laboratories, 2000–2004. See Table 4 for complete list of participating countries.
Main Article
Top of Page